Hwail Pharmaceutical Co.Ltd Free Cash Flow Generation Index
Hwail Pharmaceutical Co.Ltd free cash flow generation index. Hwail Pharmaceutical Co.Ltd (061250) has a Free Cash Flow Generation Index of 0.80x as of September 2025. Free cash flow of ₩5.44 Billion represents 1% of operating cash flow (₩6.82 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Hwail Pharmaceutical Co.Ltd (2011–2024)
Free cash flow generation index of Hwail Pharmaceutical Co.Ltd from 2011 to 2024. Historical FCF Generation Index trend for Hwail Pharmaceutical Co.Ltd across 10 annual periods. See financial agility of Hwail Pharmaceutical Co.Ltd to measure the company's free cash flow as a share of total liabilities.
Hwail Pharmaceutical Co.Ltd Free Cash Flow Generation Index by Year (2011–2024)
Hwail Pharmaceutical Co.Ltd free cash flow generation index by year from 2011 to 2024. Year-by-year Free Cash Flow Generation Index for Hwail Pharmaceutical Co.Ltd. For the full cash flow conversion analysis, see 061250 cash flow conversion.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.98x | ₩-23.00 Billion | ₩11.63 Billion | ₩34.63 Billion | ▼ -382.1% |
| 2023 | 0.70x | ₩4.92 Billion | ₩7.02 Billion | ₩2.10 Billion | ▼ -20.1% |
| 2021 | 0.88x | ₩17.62 Billion | ₩20.09 Billion | ₩2.47 Billion | ▼ -32.2% |
| 2019 | 1.29x | ₩4.78 Billion | ₩3.69 Billion | ₩1.09 Billion | ▲ +6.4% |
| 2018 | 1.22x | ₩8.72 Billion | ₩7.17 Billion | ₩1.55 Billion | ▲ +14.6% |
| 2017 | 1.06x | ₩8.85 Billion | ₩8.34 Billion | ₩513.62 Million | ▲ +1.8% |
| 2016 | 1.04x | ₩9.99 Billion | ₩9.58 Billion | ₩413.00 Million | ▼ -55.0% |
| 2013 | 2.32x | ₩16.16 Billion | ₩6.97 Billion | ₩9.18 Billion | ▼ -73.3% |
| 2012 | 8.69x | ₩8.73 Billion | ₩1.00 Billion | ₩7.72 Billion | ▲ +417.8% |
| 2011 | 1.68x | ₩13.18 Billion | ₩7.86 Billion | ₩5.32 Billion | — |